Tag: generic semaglutide launch
GENERAL Dr Reddy’s Taps Canada’s Diabetes Market With Semaglutide Injection

Dr Reddy’s Laboratories (DRL)has launched its generic Semaglutide injection in Canada, becoming among the first companies to introduce the product in the Canadian market following regulatory approval from Health Canada. The company said it received the Notice of Compliance (NOC) from Health Canada on April 28, 2026, paving the way for the commercial launch. Canada […]

CW Bureau · May 16, 2026
GENERAL Generic Semaglutide Arrives, Igniting Race For India’s Diabetes Market

The expiry of the Semaglutide patent in India has triggered a high-stakes entry of domestic pharma majors into the GLP-1 therapy space, setting the stage for intense price competition and wider patient access. With type 2 diabetes and obesity emerging as major public health challenges, companies are racing to capture a share of what is […]

Sajan C Kumar · Mar 21, 2026